TRISPECIFIC ANTIBODIES FOR PREVENTION AND TREATMENT OF HIV-1 INFECTION
Broadly neutralizing anti-HIV-1 antibodies (bnAbs) are promising candidates for use in both prevention and treatment of HIV-1. These bnAbs have been shown to be efficacious in animal models and ongoing clinical studies suggest they mediate anti-viral activity in HIV-1 infected humans. Due to the diversity of circulating HIV-1 strains, the use of a single bnAb…